MX375226B - Composición tópica que contiene ranpirnasa. - Google Patents

Composición tópica que contiene ranpirnasa.

Info

Publication number
MX375226B
MX375226B MX2017002242A MX2017002242A MX375226B MX 375226 B MX375226 B MX 375226B MX 2017002242 A MX2017002242 A MX 2017002242A MX 2017002242 A MX2017002242 A MX 2017002242A MX 375226 B MX375226 B MX 375226B
Authority
MX
Mexico
Prior art keywords
composition containing
topical composition
ranpirnase
vehicle
ribonuclease
Prior art date
Application number
MX2017002242A
Other languages
English (en)
Other versions
MX2017002242A (es
Inventor
Jamie Sulley
Luis Squiquera
Original Assignee
Tamir Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/462,520 external-priority patent/US20160045574A1/en
Application filed by Tamir Biotechnology Inc filed Critical Tamir Biotechnology Inc
Publication of MX2017002242A publication Critical patent/MX2017002242A/es
Publication of MX375226B publication Critical patent/MX375226B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
    • C12Y301/27005—Pancreatic ribonuclease (3.1.27.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Una ribonucleasa enzimáticamente activa se combina con un vehículo que no interfiere inaceptablemente con dicha actividad enzimática y se aplica externamente. Ventajosamente, la ribonucleasa es ranpirnase. El vehículo puede ser un líquido, un gel un ungüento o un suero y también poder ser un lubricante sexual aprobado.
MX2017002242A 2014-08-18 2015-08-14 Composición tópica que contiene ranpirnasa. MX375226B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/462,520 US20160045574A1 (en) 2014-08-18 2014-08-18 Antiviral pharmaceutical for topical administration
US14/793,920 US9642794B2 (en) 2014-08-18 2015-07-08 Antiviral pharmaceutical for topical administration
PCT/US2015/045272 WO2016028634A1 (en) 2014-08-18 2015-08-14 Topical composition containing ranpirnase

Publications (2)

Publication Number Publication Date
MX2017002242A MX2017002242A (es) 2017-10-12
MX375226B true MX375226B (es) 2025-03-06

Family

ID=53969458

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002242A MX375226B (es) 2014-08-18 2015-08-14 Composición tópica que contiene ranpirnasa.

Country Status (10)

Country Link
US (1) US9642794B2 (es)
EP (2) EP3851119A1 (es)
JP (2) JP6755856B2 (es)
AU (2) AU2015305819B2 (es)
BR (1) BR112017003359A2 (es)
CA (1) CA2958856A1 (es)
ES (1) ES2870590T3 (es)
IL (1) IL250649A0 (es)
MX (1) MX375226B (es)
WO (1) WO2016028634A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9919034B2 (en) 2014-03-28 2018-03-20 Tamir Biotechnology, Inc. Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V
US9642794B2 (en) 2014-08-18 2017-05-09 Tamir Biotechnology, Inc. Antiviral pharmaceutical for topical administration
US10835598B2 (en) 2014-08-18 2020-11-17 Orgenesis Inc. Prophylactic protection against viral infections, particularly HIV
CA2989611C (en) 2015-06-15 2024-02-27 Tamir Biotechnology, Inc. Pharmaceuticals for treatment of viral infections of the eye
EP3490587B1 (en) * 2016-07-26 2021-06-16 Squiquera, Luis Prophylactic protection against viral infections
US11331378B2 (en) 2016-07-26 2022-05-17 Orgenesis Inc. Prophylactic protection against viral infections
WO2021188854A1 (en) * 2020-03-20 2021-09-23 Orgenesis Inc. Ribonucleases for treating viral infections
WO2024226832A1 (en) * 2023-04-25 2024-10-31 Orgenesis Inc. Ribonucleases for treating viral infections

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559212A (en) 1988-04-06 1996-09-24 Alfacell Corporation Frog embryo and egg-derived tumor cell anti-proliferation protein
US5728805A (en) 1988-04-06 1998-03-17 Alfacell Corp. Pharmaceuticals and method for making them
US7220427B2 (en) 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US6239257B1 (en) 1998-12-30 2001-05-29 Alfacell Corporation Family of proteins belonging to the pancreatic ribonuclease a superfamily
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
US6175003B1 (en) 1999-09-10 2001-01-16 Alfacell Corporation Nucleic acids encoding ribonucleases and methods of making them
US7229824B2 (en) 2003-07-17 2007-06-12 Alfacell Corporation Ribonucleases and methods of making them recombinantly
US8551480B2 (en) 2004-02-13 2013-10-08 Immunomedics, Inc. Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
WO2009088992A2 (en) 2008-01-07 2009-07-16 University Of Vermont And State Agricultural College Ribonuclease and thiazolidinedione compounds and their use in methods to treat cancer
SG171828A1 (en) 2008-11-26 2011-07-28 Us Gov Health & Human Serv Virus like particle compositions and methods of use
CA2782441A1 (en) * 2009-12-01 2011-06-09 Seprox Biotech, S.L. Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
US8518399B2 (en) 2010-11-17 2013-08-27 Tamir Biotechnology, Inc. Methods of treating infections originating from viruses in the herpesviridae family
US8663964B2 (en) * 2011-07-20 2014-03-04 Tamir Biotechnology, Inc. Methods of treating human papillomavirus
US9642794B2 (en) 2014-08-18 2017-05-09 Tamir Biotechnology, Inc. Antiviral pharmaceutical for topical administration

Also Published As

Publication number Publication date
US20160045431A1 (en) 2016-02-18
MX2017002242A (es) 2017-10-12
EP3185890A1 (en) 2017-07-05
US9642794B2 (en) 2017-05-09
JP6755856B2 (ja) 2020-09-16
JP2020196745A (ja) 2020-12-10
JP2017525715A (ja) 2017-09-07
ES2870590T3 (es) 2021-10-27
WO2016028634A1 (en) 2016-02-25
EP3851119A1 (en) 2021-07-21
AU2015305819B2 (en) 2020-09-10
AU2015305819A1 (en) 2017-03-16
CA2958856A1 (en) 2016-02-25
AU2020286210A1 (en) 2021-01-07
IL250649A0 (en) 2017-04-30
BR112017003359A2 (pt) 2018-01-23
EP3185890B1 (en) 2021-01-20

Similar Documents

Publication Publication Date Title
MX375226B (es) Composición tópica que contiene ranpirnasa.
EP4234689A3 (en) Split inteins with exceptional splicing activity
TWD170361S (zh) 全地形車之部分
TWD196826S (zh) 智慧型機器人
MX376405B (es) Método de asistencia de estacionamiento y dispositivo de asistencia de estacionamiento.
TWD200240S (zh) 智慧型機器人
MX2017012830A (es) Asistencia al vehiculo.
TWD190519S (zh) 車輛前上護柵
TWD194575S (zh) 垃圾桶
EP3662615A4 (en) CLOUD-TYPE MULTI-CLIENT CALCULATION PRESERVING CONFIDENTIALITY WITH APPLICATION TO SECURE NAVIGATION
MY192918A (en) Combination therapies with anti-cd38 antibodies
TWD192214S (zh) 電子裝置
MX373006B (es) Sumario post-manejo con tutorial.
AU353725S (en) All terrain vehicle
TWD195345S (zh) 轉換器
GB2549650A (en) Techniques for sharing applications
HK1216987A1 (zh) 微生物组调制指数
TWD166713S (zh) 用於基板托盤的封接件
CA2854781A1 (en) Stabilizing support for a downspout extension
MX2018006509A (es) Dispositivo estabilizador de vehiculo.
BR112017016108A2 (pt) sistema e método para facilitar a comunicação
GB2520444A (en) Firmware agent
MX382039B (es) Miembro de suspensión para vehículos.
TWD172520S (zh) 車用燈具之部分
TWD180565S (zh) 塗抹器

Legal Events

Date Code Title Description
FG Grant or registration